Vennis Hong

4.1k total citations · 3 hit papers
54 papers, 2.2k citations indexed

About

Vennis Hong is a scholar working on Infectious Diseases, Health and Epidemiology. According to data from OpenAlex, Vennis Hong has authored 54 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Infectious Diseases, 17 papers in Health and 16 papers in Epidemiology. Recurrent topics in Vennis Hong's work include SARS-CoV-2 and COVID-19 Research (28 papers), COVID-19 Clinical Research Studies (19 papers) and Vaccine Coverage and Hesitancy (17 papers). Vennis Hong is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (28 papers), COVID-19 Clinical Research Studies (19 papers) and Vaccine Coverage and Hesitancy (17 papers). Vennis Hong collaborates with scholars based in United States, United Kingdom and Thailand. Vennis Hong's co-authors include Sara Y. Tartof, Bradley K. Ackerson, Luis Jódar, John M. McLaughlin, Heidi Fischer, Jeff Slezak, Srinivas Rao Valluri, Joseph A. Lewnard, Timothy B. Frankland and Oluwaseye Ayoola Ogun and has published in prestigious journals such as The Lancet, Nature Medicine and Nature Communications.

In The Last Decade

Vennis Hong

51 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study

2021 727 citations Sara Y. Tartof, Jeff Slezak et al. profile →
Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California

2022 214 citations Joseph A. Lewnard, Vennis Hong et al. profile →
Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system

2023 74 citations Joseph A. Lewnard, John M. McLaughlin et al. profile →

Peers

Countries citing papers authored by Vennis Hong

Since Specialization

Citations

This map shows the geographic impact of Vennis Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vennis Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vennis Hong more than expected).

Fields of papers citing papers by Vennis Hong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vennis Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vennis Hong. The network helps show where Vennis Hong may publish in the future.

Co-authorship network of co-authors of Vennis Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Vennis Hong. A scholar is included among the top collaborators of Vennis Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vennis Hong. Vennis Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A three-part model for the self-controlled case series design to estimate and characterize adverse event risk in an overlapping risk period after multiple vaccines: application to ischemic stroke following Pfizer-BioNTech bivalent COVID-19 vaccine and influenza vaccine 2025 ·American Journal of Epidemiology ·Stanley Xu, Lina S. Sy, (unknown), Vennis Hong, (unknown), Katia Bruxvoort, Bruno Lewin, (unknown), Lei Qian	0
2	Development and validation of a clinical prediction tool for non-receipt of updated COVID-19 vaccines 2025 ·Vaccine ·Katia Bruxvoort, Lina S. Sy, Richard Contreras, Bruno Lewin, Vennis Hong, Lei Qian, (unknown), Bing Han, Stanley Xu	2
3	Respiratory syncytial virus vaccine uptake among adults aged ≥60 years in a large, integrated healthcare system in Southern California 2023–2024 2025 ·Vaccine ·Rudy Patrick, Parag Mahale, Bradley K. Ackerson, Vennis Hong, Sally F. Shaw, (unknown), (unknown), Matthew Feaster, Jeff Slezak, Julie Stern, Gregg S. Davis, Guy M. Goodwin, Bruno Lewin, Joseph A. Lewnard, Hung Fu Tseng, Sara Y. Tartof	2
4	Comparative risk of post-acute sequelae following SARS-CoV-2 or influenza virus infection: A retrospective cohort study among United States adults 2025 ·PLoS Medicine ·Joseph A. Lewnard, Deborah E. Malden, Vennis Hong, (unknown), Leora R. Feldstein, Sharon Saydah, Iris Reyes, Rulin C. Hechter, Lina S. Sy, Bradley K. Ackerson, Sara Y. Tartof	0
5	Association of Pneumococcal Conjugate Vaccination With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Older Adult Recipients of Coronavirus Disease 2019 Vaccines: A Longitudinal Cohort Study 2024 ·The Journal of Infectious Diseases ·Joseph A. Lewnard, Vennis Hong, Lindsay R. Grant, Bradley K. Ackerson, Katia Bruxvoort, (unknown), Adriano Arguedas, Alejandro Cané, Luis Jódar, (unknown), Sara Y. Tartof	0
6	Immune escape and attenuated severity associated with the SARS-CoV-2 BA.2.86/JN.1 lineage 2024 ·Nature Communications ·Joseph A. Lewnard, Parag Mahale, Deborah E. Malden, Vennis Hong, Bradley K. Ackerson, Bruno Lewin, Ruth Link‐Gelles, Leora R. Feldstein, Marc Lipsitch, Sara Y. Tartof	8
7	A propensity score approach and a partitioned approach for the self-controlled case series design to evaluate safety of a 2-dose vaccine series: application to myocarditis/pericarditis following mRNA COVID-19 vaccination 2024 ·American Journal of Epidemiology ·Stanley Xu, Lina S. Sy, (unknown), Vennis Hong, Katia Bruxvoort, Bruno Lewin, (unknown), Lei Qian	3
8	Ischemic Stroke After Bivalent COVID-19 Vaccination: Self-Controlled Case Series Study 2024 ·JMIR Public Health and Surveillance ·Stanley Xu, Lina S. Sy, Vennis Hong, (unknown), Lei Qian, Paddy Farrington, Katia Bruxvoort, Nicola P. Klein, Bruce Fireman, (unknown), Bruno Lewin	4
9	Burden of Lower Respiratory Tract Infections Preventable by Adult Immunization With 15- and 20-Valent Pneumococcal Conjugate Vaccines in the United States 2023 ·Clinical Infectious Diseases ·Joseph A. Lewnard, Vennis Hong, Katia Bruxvoort, Lindsay R. Grant, Luis Jódar, Alejandro Cané, Adriano Arguedas, (unknown), Bradford D. Gessner, Sara Y. Tartof	7
10	Real‐World Evidence to Supplement Randomized Clinical Trials: Tocilizumab for Severe COVID‐19 Pneumonia vs. a Cohort Receiving Standard of Care 2023 ·Clinical Pharmacology & Therapeutics ·Jacek Skarbinski, Heidi Fischer, Vennis Hong, Liyan Liu, Vincent Yau, Devin Incerti, Lei Qian, Bradley K. Ackerson, Laura B. Amsden, Sally F. Shaw, Sara Y. Tartof	3
11	Impact of California’s Senate Bill 27 on Antimicrobial-Resistant Escherichia coli Urinary Tract Infection in Humans: Protocol for a Study of Methods and Baseline Data 2023 ·JMIR Research Protocols ·Ana Florea, Joan A. Casey, Keeve E. Nachman, Lance B. Price, (unknown), Harpreet S. Takhar, (unknown), (unknown), Meghan F. Davis, Rong Wei, Vennis Hong, Jennifer H Ku, Cindy M. Liu, Alice Pressman, Sarah Robinson, Katia Bruxvoort, (unknown), Sara Y. Tartof	1
12	Analysis of mRNA COVID-19 Vaccine Uptake Among Immunocompromised Individuals in a Large US Health System 2023 ·JAMA Network Open ·Sara Y. Tartof, Jeff Slezak, Laura Puzniak, Vennis Hong, Timothy B. Frankland, Fagen Xie, Bradley K. Ackerson, Harpreet S. Takhar, Oluwaseye Ayoola Ogun, Sarah Simmons, Joann M. Zamparo, Hung Fu Tseng, Luis Jódar, John M. McLaughlin	18
13	Risk Factors for Not Completing a 2-Dose Primary Series of Messenger RNA COVID-19 Vaccination in a Large Health Care System in Southern California: Retrospective Cohort Study 2023 ·JMIR Public Health and Surveillance ·Stanley Xu, Vennis Hong, Lina S. Sy, Katia Bruxvoort, Bruno Lewin, (unknown), (unknown), Lei Qian	1
14	Risk of subsequent lower respiratory tract infection (LRTI) after hospitalization for COVID-19 LRTI and non-COVID-19 LRTI: a retrospective cohort study 2023 ·SHILAP Revista de lepidopterología ·Katia Bruxvoort, Heidi Fischer, Joseph A. Lewnard, Vennis Hong, (unknown), Lindsay R. Grant, Luis Jódar, Bradford D. Gessner, Sara Y. Tartof	2
15	Retrospective cohort study to assess the association between treatment with tocilizumab and mortality among mechanically ventilated patients with COVID-19 2022 ·BMJ Open ·Jacek Skarbinski, Liyan Liu, Vennis Hong, Laura B. Amsden, Bruce Fireman, Vincent Yau, Devin Incerti, Lei Qian, Heidi Fischer, Bradley K. Ackerson, Sally F. Shaw, Sara Y. Tartof	1
16	Natural Language Processing for Improved Characterization of COVID-19 Symptoms: Observational Study of 350,000 Patients in a Large Integrated Health Care System 2022 ·JMIR Public Health and Surveillance ·Deborah E. Malden, Sara Y. Tartof, Bradley K. Ackerson, Vennis Hong, Jacek Skarbinski, Vincent Yau, Lei Qian, Heidi Fischer, Sally F. Shaw, Susan Caparosa, Fagen Xie	17
17	Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic 2022 ·Vaccine ·Stanley Xu, Vennis Hong, Lina S. Sy, Sungching Glenn, Denison S Ryan, (unknown), Jennifer C. Nelson, Simon J. Hambidge, Bradley Crane, Ousseny Zerbo, Malini B. DeSilva, Jason M. Glanz, James G. Donahue, Elizabeth Liles, Jonathan Duffy, Lei Qian	9
18	Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Medically Attended Lower Respiratory Tract Infection and Pneumonia Among Older Adults 2021 ·Clinical Infectious Diseases ·Joseph A. Lewnard, Katia Bruxvoort, Heidi Fischer, Vennis Hong, Lindsay R. Grant, Luis Jódar, Alejandro Cané, Bradford D. Gessner, Sara Y. Tartof	31
19	Correction: Impact of the COVID-19 Pandemic on Health Care Utilization in a Large Integrated Health Care System: Retrospective Cohort Study 2021 ·Journal of Medical Internet Research ·Stanley Xu, Sungching Glenn, Lina S. Sy, Lei Qian, Vennis Hong, Denison S Ryan, Steven J. Jacobsen	3
20	Disparities in Outpatient and Telehealth Visits During the COVID-19 Pandemic in a Large Integrated Health Care Organization: Retrospective Cohort Study 2021 ·Journal of Medical Internet Research ·Lei Qian, Lina S. Sy, Vennis Hong, Sungching Glenn, Denison S Ryan, (unknown), Steven J. Jacobsen, Stanley Xu	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact